Market Cap 395.43M
Revenue (ttm) 30.91M
Net Income (ttm) -209.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -677.68%
Debt to Equity Ratio 0.89
Volume 2,967,700
Avg Vol 2,568,208
Day's Range N/A - N/A
Shares Out 87.87M
Stochastic %K 94%
Beta 0.29
Analysts Strong Sell
Price Target $15.12

Company Profile

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers; and Defactinib, an oral small mole...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 292 4200
Address:
117 Kendrick Street, Suite 500, Needham, United States
StockScanners
StockScanners Jul. 4 at 5:07 PM
$VSTM keep watch if this holds above 4.45
0 · Reply
CliffordCapital
CliffordCapital Jul. 4 at 9:21 AM
$PLX happy July 4th to my American brothers and sisters!! May god bless you $WVE $IREN $EOSE $VSTM
0 · Reply
Drew613
Drew613 Jul. 3 at 1:58 PM
$VSTM nice article on VSTM. I will be adding more next week. Very https://finance.yahoo.com/healthcare/articles/rbc-capital-verastem-vstm-131336671.html
0 · Reply
focafoca99
focafoca99 Jul. 2 at 9:07 PM
$VSTM grant inducement RSUs and options to new hires under Nasdaq Rule 5635(c)(4). https://www.rapidticker.com/news/vstm-verastem-oncology-announces-inducement-grants-72659c
0 · Reply
sweddle
sweddle Jul. 2 at 8:00 PM
$VSTM happy Independence Day all
1 · Reply
tonkotsu
tonkotsu Jul. 2 at 7:25 PM
$VSTM Yoo Vstm crew, any other super undervalued biotech unfairly punished right now?
6 · Reply
Alt_Fuel
Alt_Fuel Jul. 2 at 7:21 PM
$VSTM $RVMD Revolution Medicines sees large block trade worth $196.7 million Published 07/02/2026, 02:44 PM Investing.com -- Revolution Medicines Inc. saw a block trade of 1.06 million shares today, representing 0.5% of the company’s float. The transaction occurred at 2:41 p.m. New York time with a market value of $196.7 million. The shares traded at $185.90 each, marking a 1.3% discount from the opening price. Revolution Medicines declined 0.9% today. The stock has gained 133% since the start of the year. The block trade accounted for 31% of the company’s 20-day average trading volume. Total trading volume reached 2.15 million shares by the time of the block trade, compared with the 20-day average of 1.67 million shares for that time of day. Bloomberg’s model projects the total volume will reach 2.16 million shares by the end of the trading session. https://www.investing.com/news/stock-market-news/revolution-medicines-sees-large-block-trade-worth-1967-million-93CH-4773894
0 · Reply
sweddle
sweddle Jul. 2 at 5:33 PM
1 · Reply
Thor1980
Thor1980 Jul. 2 at 4:44 PM
$VSTM come to $TOP an Break 2$ and back to $256
0 · Reply
Goyl
Goyl Jul. 2 at 4:36 PM
$VSTM lots are holding between $8 and $13 for break even .. newer $$ from $3.70 called bottom here will be tempted to sell with 25% gains.. but , but , .. it’s a given retail fact that fear causes more % of loses than patience for not leaving $$ on the table. We are bouncing if the bottom of a weekly chart , the top channel is $10.00. Sit on your hands , go touch grass. 🎯 $12
0 · Reply
Latest News on VSTM
Verastem Transcript: Study update

Jun 23, 2026, 4:30 PM EDT - 10 days ago

Verastem Transcript: Study update


Verastem Press release: Study update

Jun 23, 2026, 4:30 PM EDT - 10 days ago

Verastem Press release: Study update


Verastem Slides: Study update

Jun 23, 2026, 4:30 PM EDT - 10 days ago

Verastem Slides: Study update


Verastem price target lowered to $8 from $15 at Jefferies

2026-06-23T17:03:54.000Z - 11 days ago

Verastem price target lowered to $8 from $15 at Jefferies


Verastem announces FDA Fast Track designation for VS-7375

2026-06-03T20:06:01.000Z - 4 weeks ago

Verastem announces FDA Fast Track designation for VS-7375


Verastem Oncology to Present at Jefferies Healthcare Conference

May 27, 2026, 7:30 AM EDT - 5 weeks ago

Verastem Oncology to Present at Jefferies Healthcare Conference


Verastem appoints Michael Bailey to board of directors

2026-05-26T12:54:22.000Z - 5 weeks ago

Verastem appoints Michael Bailey to board of directors


Verastem price target lowered to $14 from $16 at Mizuho

2026-05-14T12:35:05.000Z - 7 weeks ago

Verastem price target lowered to $14 from $16 at Mizuho


Verastem Oncology to Present at Upcoming Investor Conferences

May 12, 2026, 7:30 AM EDT - 7 weeks ago

Verastem Oncology to Present at Upcoming Investor Conferences


Verastem price target lowered to $18 from $19 at BTIG

2026-05-08T12:55:59.000Z - 2 months ago

Verastem price target lowered to $18 from $19 at BTIG


Verastem price target raised to $18 from $16 at Alliance Global

2026-05-08T11:20:06.000Z - 2 months ago

Verastem price target raised to $18 from $16 at Alliance Global


Verastem reports Q1 adjusted EPS (43c), consensus (47c)

2026-05-07T21:47:04.000Z - 2 months ago

Verastem reports Q1 adjusted EPS (43c), consensus (47c)


Verastem Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Verastem Earnings Call Transcript: Q1 2026


Verastem Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Verastem Earnings release: Q1 2026


Verastem Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Verastem Quarterly report: Q1 2026


Verastem Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Verastem Slides: Q1 2026


Verastem announces launch of Reimagine Recurrent LGSOC campaign

2026-04-30T11:53:49.000Z - 2 months ago

Verastem announces launch of Reimagine Recurrent LGSOC campaign


Verastem Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 3 months ago

Verastem Proxy statement: Proxy filing


Verastem assumed with a Buy at Jefferies

2026-03-30T13:00:48.000Z - 3 months ago

Verastem assumed with a Buy at Jefferies


Verastem management to meet with Cantor

2026-03-26T21:06:04.000Z - 3 months ago

Verastem management to meet with Cantor


Verastem assumed with a Buy at BTIG

2026-03-11T20:28:30.000Z - 4 months ago

Verastem assumed with a Buy at BTIG


Verastem price target raised to $18 from $16 at Alliance Global

2026-03-05T12:09:05.000Z - 4 months ago

Verastem price target raised to $18 from $16 at Alliance Global


Verastem Earnings Call Transcript: Q4 2025

Mar 4, 2026, 4:30 PM EST - 4 months ago

Verastem Earnings Call Transcript: Q4 2025


Verastem Earnings release: Q4 2025

Mar 4, 2026, 4:30 PM EST - 4 months ago

Verastem Earnings release: Q4 2025


Verastem Annual report: Q4 2025

Mar 4, 2026, 4:30 PM EST - 4 months ago

Verastem Annual report: Q4 2025


Verastem Slides: Q4 2025

Mar 4, 2026, 4:30 PM EST - 4 months ago

Verastem Slides: Q4 2025


Verastem Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 9:30 AM EST - 8 months ago

Verastem Transcript: Jefferies London Healthcare Conference 2025


Verastem Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Verastem Earnings Call Transcript: Q3 2025


Verastem Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Verastem Quarterly report: Q3 2025


Verastem Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 8 months ago

Verastem Earnings release: Q3 2025


Verastem Transcript: Cantor Global Healthcare Conference 2025

Sep 3, 2025, 3:55 PM EDT - 10 months ago

Verastem Transcript: Cantor Global Healthcare Conference 2025


Verastem Registration statement: Registration Filing

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Verastem Registration statement: Registration Filing


Verastem Registration statement: Registration Filing

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Verastem Registration statement: Registration Filing


Verastem Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Verastem Earnings Call Transcript: Q2 2025


Verastem Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Verastem Earnings release: Q2 2025


Verastem Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Verastem Quarterly report: Q2 2025


Verastem Transcript: R&D Day 2025

Jun 2, 2025, 12:00 PM EDT - 1 year ago

Verastem Transcript: R&D Day 2025


Verastem Slides: FY 2025

Jun 2, 2025, 12:00 PM EDT - 1 year ago

Verastem Slides: FY 2025


Verastem Registration statement: Registration Filing

May 13, 2025, 8:00 AM EDT - 1 year ago

Verastem Registration statement: Registration Filing


Verastem Earnings release: Q1 2025

May 12, 2025, 6:00 PM EDT - 1 year ago

Verastem Earnings release: Q1 2025


Verastem Quarterly report: Q1 2025

May 12, 2025, 6:00 PM EDT - 1 year ago

Verastem Quarterly report: Q1 2025


U.S. FDA approves Verastem's cancer therapy

May 8, 2025, 12:23 PM EDT - 1 year ago

U.S. FDA approves Verastem's cancer therapy


Verastem Oncology Announces $75 million Private Placement

Apr 25, 2025, 9:00 AM EDT - 1 year ago

Verastem Oncology Announces $75 million Private Placement


Verastem Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Verastem Proxy statement: Proxy Filing


Verastem Registration statement: Registration Filing

Mar 20, 2025, 8:00 AM EDT - 1 year ago

Verastem Registration statement: Registration Filing


Verastem Annual report: Q4 2024

Mar 19, 2025, 7:00 PM EDT - 1 year ago

Verastem Annual report: Q4 2024


Verastem Transcript: Guggenheim SMID Cap Biotech Conference

Feb 5, 2025, 1:00 PM EST - 1 year ago

Verastem Transcript: Guggenheim SMID Cap Biotech Conference


StockScanners
StockScanners Jul. 4 at 5:07 PM
$VSTM keep watch if this holds above 4.45
0 · Reply
CliffordCapital
CliffordCapital Jul. 4 at 9:21 AM
$PLX happy July 4th to my American brothers and sisters!! May god bless you $WVE $IREN $EOSE $VSTM
0 · Reply
Drew613
Drew613 Jul. 3 at 1:58 PM
$VSTM nice article on VSTM. I will be adding more next week. Very https://finance.yahoo.com/healthcare/articles/rbc-capital-verastem-vstm-131336671.html
0 · Reply
focafoca99
focafoca99 Jul. 2 at 9:07 PM
$VSTM grant inducement RSUs and options to new hires under Nasdaq Rule 5635(c)(4). https://www.rapidticker.com/news/vstm-verastem-oncology-announces-inducement-grants-72659c
0 · Reply
sweddle
sweddle Jul. 2 at 8:00 PM
$VSTM happy Independence Day all
1 · Reply
tonkotsu
tonkotsu Jul. 2 at 7:25 PM
$VSTM Yoo Vstm crew, any other super undervalued biotech unfairly punished right now?
6 · Reply
Alt_Fuel
Alt_Fuel Jul. 2 at 7:21 PM
$VSTM $RVMD Revolution Medicines sees large block trade worth $196.7 million Published 07/02/2026, 02:44 PM Investing.com -- Revolution Medicines Inc. saw a block trade of 1.06 million shares today, representing 0.5% of the company’s float. The transaction occurred at 2:41 p.m. New York time with a market value of $196.7 million. The shares traded at $185.90 each, marking a 1.3% discount from the opening price. Revolution Medicines declined 0.9% today. The stock has gained 133% since the start of the year. The block trade accounted for 31% of the company’s 20-day average trading volume. Total trading volume reached 2.15 million shares by the time of the block trade, compared with the 20-day average of 1.67 million shares for that time of day. Bloomberg’s model projects the total volume will reach 2.16 million shares by the end of the trading session. https://www.investing.com/news/stock-market-news/revolution-medicines-sees-large-block-trade-worth-1967-million-93CH-4773894
0 · Reply
sweddle
sweddle Jul. 2 at 5:33 PM
1 · Reply
Thor1980
Thor1980 Jul. 2 at 4:44 PM
$VSTM come to $TOP an Break 2$ and back to $256
0 · Reply
Goyl
Goyl Jul. 2 at 4:36 PM
$VSTM lots are holding between $8 and $13 for break even .. newer $$ from $3.70 called bottom here will be tempted to sell with 25% gains.. but , but , .. it’s a given retail fact that fear causes more % of loses than patience for not leaving $$ on the table. We are bouncing if the bottom of a weekly chart , the top channel is $10.00. Sit on your hands , go touch grass. 🎯 $12
0 · Reply
DrTim
DrTim Jul. 2 at 4:27 PM
$VSTM Those panic sells in the mid 3s last week are looking rather foolish right now!
1 · Reply
Alt_Fuel
Alt_Fuel Jul. 2 at 4:17 PM
$VSTM $RVMD News today - so far RVMD price DOWN by 1.27 % while $VSTM price is UP by 11.22 % Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026 July 2, 2026 https://ir.revmed.com/news-releases/news-release-details/revolution-medicines-presents-phase-12-clinical-data-zoldonrasib
1 · Reply
Jtlo
Jtlo Jul. 2 at 4:15 PM
$VSTM lol raise it up to drop an offering? Bios are always funa hopefully a nice surpirse
0 · Reply
UWilDue0
UWilDue0 Jul. 2 at 4:11 PM
$VSTM XBI is starting its 14th green monthly candle right at a double top yet this decides to start going up now?
0 · Reply
sweddle
sweddle Jul. 2 at 4:08 PM
0 · Reply
alexx013
alexx013 Jul. 2 at 3:37 PM
1 · Reply
Stoltz13
Stoltz13 Jul. 2 at 3:16 PM
$VSTM I have a feeling this is going to explode. Definitely not one I would sleep on ...
1 · Reply
sweddle
sweddle Jul. 2 at 3:05 PM
1 · Reply
boston_drew
boston_drew Jul. 2 at 3:03 PM
$VSTM Any news today? I remember Dan mentioning that the terms of new partnership were not defined due to talks with other companies so maybe something exciting
1 · Reply
Georgeson
Georgeson Jul. 2 at 3:02 PM
$VSTM Interesting such a strong move so far and volume is only slightly above average.
0 · Reply
Goyl
Goyl Jul. 2 at 3:02 PM
$VSTM look👇🏼that was 7 days ago , up 21% demonstrates the power of averaging in when you trust your DD , management and pipeline. 🎯 $12 $XBI
0 · Reply
Goyl
Goyl Jul. 2 at 2:41 PM
$VSTM $XBI 👇🏼
1 · Reply